CHUC · Charlie'S Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $3.62M | - | $994.0K | - | - | - | - | - | - | - |
| Gross Profit | $1.18M | - | $1.76M | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | $6.0K | - |
| SG&A | $1.74M | - | $1.69M | $1.41M | $1.13M | - | $1.42M | $1.42M | $1.54M | - |
| Total Operating Expenses | $2.15M | - | $2.10M | $3.42M | $3.13M | - | $2.50M | $2.78M | $3.99M | - |
| D&A | $6.0K | - | - | - | $13.0K | - | - | - | $37.0K | - |
| Operating Income | ($975.0K) | - | ($339.0K) | ($877.0K) | ($826.0K) | - | ($876.0K) | ($736.0K) | ($941.0K) | - |
| Interest Expense | $75.0K | - | $37.0K | $335.0K | $183.0K | - | $121.0K | $111.0K | $183.0K | - |
| Income Tax | $0 | - | $0 | $0 | - | - | - | - | - | - |
| Net Income | ($1.05M) | - | $624.0K | $4.96M | ($1.22M) | - | ($1.02M) | ($967.0K) | ($1.04M) | - |
| EPS - Basic | $0.00 | - | $0.00 | $0.02 | $0.00 | - | $0.00 | $0.00 | $0.00 | - |
| EPS - Diluted | - | - | $0.00 | $0.02 | $0.00 | - | $0.00 | $0.00 | $0.00 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $640.0K | $1.32M | $1.15M | $1.45M | $112.0K | $211.0K | $601.0K | $1.08M | $176.0K | $367.0K |
| Accounts Receivable | $1.27M | $440.0K | $1.15M | $379.0K | $17.0K | $365.0K | $84.0K | $332.0K | $380.0K | $289.0K |
| Inventory | $10.10M | $6.72M | $4.25M | $3.62M | $2.63M | $2.67M | $2.73M | $3.20M | $3.39M | $3.83M |
| Accounts Payable | $3.37M | $3.29M | $2.23M | $1.35M | $1.62M | $2.13M | $1.81M | $1.63M | $1.43M | $1.47M |
| Current Assets | $14.12M | $10.77M | $9.84M | $5.85M | $3.00M | $3.72M | $3.94M | $4.82M | $4.19M | $5.09M |
| Total Assets | $14.85M | $11.56M | $10.56M | $5.97M | $3.17M | $3.94M | $4.22M | $5.23M | $4.73M | $5.77M |
| Current Liabilities | $9.27M | $7.63M | $6.76M | $3.63M | $5.83M | $5.58M | $5.33M | $5.37M | $5.64M | $4.75M |
| Long-term Debt | - | - | - | - | $3.14M | $2.16M | $2.57M | $2.05M | $2.78M | $2.46M |
| Total Liabilities | $11.74M | $8.14M | $7.32M | $3.79M | $5.98M | $5.72M | $5.48M | $5.52M | $5.82M | $5.88M |
| Stockholders' Equity | $3.11M | $3.42M | $3.24M | $2.19M | ($2.81M) | ($1.78M) | ($1.26M) | ($296.0K) | ($1.09M) | ($107.0K) |
| Retained Earnings | ($9.25M) | ($8.20M) | ($8.33M) | ($8.96M) | ($13.92M) | ($12.70M) | ($11.57M) | ($10.55M) | ($9.59M) | ($8.54M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.10M) | - | - | - | ($409.0K) | - | - | - | ($431.0K) | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | $425.0K | - | - | - | $310.0K | - | - | - | $240.0K | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | 0.0% | 0.0% | - | - | - | - | - | - |
| Return on assets | -7.1% | - | 5.9% | 83.0% | -38.4% | - | -24.2% | -18.5% | -22.1% | - |
| Return on equity | -33.8% | - | 19.3% | 226.5% | 43.3% | - | 81.0% | 326.7% | 95.9% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.52 | 1.41 | 1.46 | 1.61 | 0.51 | 0.67 | 0.74 | 0.90 | 0.74 | 1.07 |
| Quick ratio | 0.43 | 0.53 | 0.83 | 0.61 | 0.06 | 0.19 | 0.23 | 0.30 | 0.14 | 0.27 |
| Cash ratio | 0.07 | 0.17 | 0.17 | 0.40 | 0.02 | 0.04 | 0.11 | 0.20 | 0.03 | 0.08 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | -1.12 | -1.21 | -2.04 | -6.91 | -2.55 | -23.03 |
| Debt / Assets | - | - | - | - | 0.99 | 0.55 | 0.61 | 0.39 | 0.59 | 0.43 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -13.0x | - | -9.2x | -2.6x | -4.5x | - | -7.2x | -6.6x | -5.1x | - |
| Equity multiplier | 4.78 | 3.38 | 3.26 | 2.73 | -1.13 | -2.22 | -3.34 | -17.66 | -4.34 | -53.91 |
| Liabilities / Assets | 0.79 | 0.70 | 0.69 | 0.63 | 1.89 | 1.45 | 1.30 | 1.06 | 1.23 | 1.02 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | 0.36 | - | 0.23 | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 1017d | - | 1561d | - | - | - | - | - | - | - |
| Days payable outstanding | 340d | - | 818d | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | 5.0x | - | - | - | - | - | - |
| P / B | 24.6x | - | 28.9x | 12.7x | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -18.0% | - | 61.3% | -19.2% | 12.2% | - | -18.1% | - | 38.0% | - |
| Net income growth (YoY) | 13.7% | - | - | - | -16.5% | - | -44.4% | - | 24.8% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | -157.7% | -1563.6% | -408.9% | - | - | - |
Peer comparison
Same SIC group: Medicinal Chemicals & Botanical Products
Comparing Charlie's Holdings against the 5 most active filers in the same SIC group.